Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.23432 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.07143 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.07245 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.03939 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.98485 | 44 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.24222 | 48 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.16363 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.05318 | 45 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.00897 | 44 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.03415 | 45 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.0677 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.04018 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.07364 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.07036 | 46 |